Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

References

• SunXHirotaSAThe roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infectionMol Immunol20156319320225242213
   PubMed Web of Science ®Google Scholar
• CarrollKCBartlettJGBiology of Clostridium difficile: implications for epidemiology and diagnosisAnnu Rev Microbiol20116550152121682645
   PubMed Web of Science ®Google Scholar
• KyneLHamelMBPolavaramRKellyCPHealth care costs and mortality associated with nosocomial diarrhea due to Clostridium difficileClin Infect Dis20023434635311774082
   PubMed Web of Science ®Google Scholar
• O’BrienJALahueBJCaroJJDavidsonDMThe emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequencesInfect Control Hosp Epidemiol2007281219122717926270
   PubMed Web of Science ®Google Scholar
• BarbutFMeynardJLGuiguetMClostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factorsJ Acquir Immune Defic Syndr Hum Retrovirol1997161761819390569
   PubMedGoogle Scholar
• BarbutFPetitJCEpidemiology of Clostridium difficile-associated infectionsClin Microbiol Infect2001740541011591202
   PubMed Web of Science ®Google Scholar
• BrownETalbotGHAxelrodPProvencherMHoeggCRisk factors for Clostridium difficile toxin-associated diarrheaInfect Control Hosp Epidemiol1990112832902373850
   PubMed Web of Science ®Google Scholar
• HutinYMolinaJMCasinIRisk factors for Clostridium difficile-associated diarrhoea in HIV-infected patientsAIDS19937144114478280409
   PubMed Web of Science ®Google Scholar
• LooVGBourgaultAMPoirierLHost and pathogen factors for Clostridium difficile infection and colonizationN Engl J Med20113651693170322047560
   PubMed Web of Science ®Google Scholar
• PakyzALJawaharRWangQHarpeSEMedication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centresJ Antimicrob Chemother2014691127113124327619
   PubMed Web of Science ®Google Scholar
• BrownKAKhanaferNDanemanNFismanDNMeta-analysis of antibiotics and the risk of community-associated Clostridium difficile infectionAntimicrob Agents Chemother2013572326233223478961
   PubMed Web of Science ®Google Scholar
• MayfieldJLLeetTMillerJMundyLMEnvironmental control to reduce transmission of Clostridium difficileClin Infect Dis200031995100011049782
   PubMed Web of Science ®Google Scholar
• RuppMECavalieriRJLydenEEffect of hospital-wide chlorhexidine patient bathing on healthcare-associated infectionsInfect Control Hosp Epidemiol2012331094110023041806
   PubMed Web of Science ®Google Scholar
• SullivanANordCEProbiotics in human infectionsJ Antimicrob Chemother20025062562712407117
   PubMed Web of Science ®Google Scholar
• GuarnerFKhanAGGarischJWorld Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011J Clin Gastroenterol20124646848122688142
   PubMed Web of Science ®Google Scholar
• HempelSNewberrySJMaherARProbiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysisJAMA20123071959196922570464
   PubMed Web of Science ®Google Scholar
• JohnstonBCMaSSGoldenbergJZProbiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysisAnn Intern Med201215787888823362517
   PubMed Web of Science ®Google Scholar
• GoldenbergJZMaSSSaxtonJDProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and childrenCochrane Database Syst Rev20135CD00609523728658
   PubMed Web of Science ®Google Scholar
• AllenSJWarehamKWangDA high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)Health Technol Assess2013171140
   Web of Science ®Google Scholar
• ShanLSHouPWangZJPrevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infectionsBenef Microbes2013432933424311316
   PubMed Web of Science ®Google Scholar
• WongSJamousAO’DriscollJA Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trialBr J Nutr201411167267824044687
   PubMed Web of Science ®Google Scholar
• OuwehandACDongLianCWeijianXProbiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response studyVaccine20143245846324291194
   PubMed Web of Science ®Google Scholar
• HallICO’TooleEIntestinal flora in newborn infants with a description of a new pathogenic anaerobe, Bacillus difficilisAm J Dis Child193549390402
   Google Scholar
• KellyCPPothoulakisCLaMontJTClostridium difficile colitisN Engl J Med19943302572628043060
   PubMed Web of Science ®Google Scholar
• RupnikMWilcoxMHGerdingDNClostridium difficile infection: new developments in epidemiology and pathogenesisNat Rev Microbiol2009752653619528959
   PubMed Web of Science ®Google Scholar
• ToKBNapolitanoLMClostridium difficile infection: update on diagnosis, epidemiology, and treatment strategiesSurg Infect (Larchmt)20141549050225314344
   PubMed Web of Science ®Google Scholar
• RevelesKRLeeGCBoydNKFreiCRThe rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001–2010Am J Infect Control2014421028103225278388
   PubMed Web of Science ®Google Scholar
• CohenSHGerdingDNJohnsonSClinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)Infect Control Hosp Epidemiol20103143145520307191
   PubMed Web of Science ®Google Scholar
• WarnyMPepinJFangAToxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeLancet20053661079108416182895
   PubMed Web of Science ®Google Scholar
• HeMMiyajimaFRobertsPEmergence and global spread of epidemic healthcare-associated Clostridium difficileNat Genet20134510911323222960
   PubMed Web of Science ®Google Scholar
• ZilberbergMDShorrAFPreventing Clostridium difficile infection in the intensive care unitCrit Care Clin201329111823182524
   PubMed Web of Science ®Google Scholar
• MerriganMVenugopalAMallozziMHuman hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin productionJ Bacteriol20101924904491120675495
   PubMed Web of Science ®Google Scholar
• MathurHReaMCCotterPDRossRPHillCThe potential for emerging therapeutic options for Clostridium difficile infectionGut Microbes2014569671025564777
   PubMed Web of Science ®Google Scholar
• CammarotaGMasucciLIaniroGRandomised clinical trial: faecal microbiota transplantation by colonoscopy vs vancomycin for the treatment of recurrent Clostridium difficile infectionAliment Pharmacol Ther20154183584325728808
   PubMed Web of Science ®Google Scholar
• BorodyTFischerMMitchellSCampbellJFecal microbiota transplantation in gastrointestinal disease: 2015 update and the road aheadExpert Rev Gastroenterol Hepatol20159111379139126414076
   PubMed Web of Science ®Google Scholar
• YoungsterISaukJPindarCFecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot studyClin Infect Dis2014581515152224762631
   PubMed Web of Science ®Google Scholar
• RohdeCLBartoliniVJonesNThe use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrheaNutr Clin Pract200924334019244146
   PubMed Web of Science ®Google Scholar
• JonesSEVersalovicJProbiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factorsBMC Microbiol200993519210794
   PubMed Web of Science ®Google Scholar
• FordACQuigleyEMLacyBEEfficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysisAm J Gastroenterol20141091547156125070051
   PubMed Web of Science ®Google Scholar
• ShenJZuoZXMaoAPEffect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn’s disease, and pouchitis: meta-analysis of randomized controlled trialsInflamm Bowel Dis201420213524280877
   PubMed Web of Science ®Google Scholar
• SalariPNikfarSAbdollahiMA meta-analysis and systematic review on the effect of probiotics in acute diarrheaInflamm Allergy Drug Targets20121131422309079
   PubMedGoogle Scholar
• DumanDGBorSOzutemizOEfficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradicationEur J Gastroenterol Hepatol2005171357136116292090
   PubMed Web of Science ®Google Scholar
• HempelSNewberrySRuelazASafety of probiotics used to reduce risk and prevent or treat diseaseEvid Rep Technol Assess (Full Rep)2011164523126627
   PubMedGoogle Scholar
• ThomasMRLitinSCOsmonDRCorrAPWeaverALLohseCMLack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trialMayo Clin Proc20017688388911560298
   PubMed Web of Science ®Google Scholar
• BeausoleilMFortierNGuenetteSEffect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trialCan J Gastroenterol20072173273618026577
   PubMed Web of Science ®Google Scholar
• CindorukMErkanGKarakanTDursunAUnalSEfficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylor i therapy: a prospective randomized placebo-controlled double-blind studyHelicobacter20071230931617669103
   PubMed Web of Science ®Google Scholar
• LonnermarkEFrimanVLappasGSandbergTBerggrenAAdlerberthIIntake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibioticsJ Clin Gastroenterol20104410611219727002
   PubMed Web of Science ®Google Scholar
• McFarlandLVSurawiczCMGreenbergRNPrevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placeboAm J Gastroenterol1995904394487872284
   PubMed Web of Science ®Google Scholar
• SurawiczCMElmerGWSpeelmanPMcFarlandLVChinnJvanBGPrevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective studyGastroenterology1989969819882494098
   PubMed Web of Science ®Google Scholar
• ArvolaTLaihoKTorkkeliSProphylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized studyPediatrics1999104e6410545590
   PubMed Web of Science ®Google Scholar
• PlummerSWeaverMAHarrisJCDeePHunterJClostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoeaInt Microbiol20047596215179608
   PubMed Web of Science ®Google Scholar
• KotowskaMAlbrechtPSzajewskaHSaccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trialAliment Pharmacol Ther20052158359015740542
   PubMed Web of Science ®Google Scholar
• CanMBesirbelliogluBAAvciIYBekerCMPahsaAProphylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective studyMed Sci Monit200612I19I22
   Web of Science ®Google Scholar
• HicksonMD’SouzaALMuthuNUse of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trialBMJ20073358017604300
   PubMed Web of Science ®Google Scholar
• RafiqRPandeyDOsmanSMMasoodRDonepudiINorkusEPrevention of Clostridium difficile (C-difficile) diarrhea with probiotic in hospitalized patients treated with antibiotics [abstract]Gastroenterology2007132Suppl 2A187
   Google Scholar
• MillerMFlorencioSEastmondJReynoldsSResults of 2 prospective randomized studies of Lactobacillus GG to prevent C. difficile infection in hospitalized adults receiving antibiotics [abstract]Abstract of the Interscience Conference on Antimicrobial Agents and Chemotherapy200848578579
   Google Scholar
• RuszczynskiMRadzikowskiASzajewskaHClinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in childrenAliment Pharmacol Ther20082815416118410562
   PubMed Web of Science ®Google Scholar
• SafdarNBarigalaRSaidAMcKinleyLFeasibility and tolerability of probiotics for prevention of antibiotic-associated diarrhoea in hospitalized US military veteransJ Clin Pharm Ther20083366366819138244
   PubMed Web of Science ®Google Scholar
• WenusCGollRLokenEBBiongASHalvorsenDSFlorholmenJPrevention of antibiotic-associated diarrhoea by a fermented probiotic milk drinkEur J Clin Nutr20086229930117356555
   PubMed Web of Science ®Google Scholar
• GaoXWMubasherMFangCYReiferCMillerLEDose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patientsAm J Gastroenterol20101051636164120145608
   PubMed Web of Science ®Google Scholar
• SampalisJPsaradellisERampakakisEEfficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea – a placebo controlled double-blind randomized, multi-center studyArch Med Sci20106566422371721
   PubMed Web of Science ®Google Scholar
• PozzoniPRivaABellatorreAGSaccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trialAm J Gastroenterol201210792293122472744
   PubMed Web of Science ®Google Scholar
• SelingerCPBellACairnsALockettMSebastianSHaslamNProbiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trialJ Hosp Infect20138415916523618760
   PubMed Web of Science ®Google Scholar